Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutational spectrum for guiding the decision of adjuvant treatment in patients with resected biliary tract carcinoma.

Cancer medicine - 1 Aug 2023

Li Yunfeng, Tan Chaochao, Yin Xinmin, Zhu Siwei, Cai Rongyao, Liao Chunhong, Wu Yifei, Zeng Qihong, Cai Chengzhi, Xie Wang, He Xiangyu, Wen Hao-Quan, Lin Guomin, He Qingqing, He Tingting, Gu Peng, Liu Chang-Jun

Abstract excerpt

BACKGROUND: Systemic chemotherapy or chemoradiation therapy has proven to be effective in treating advanced biliary tract carcinoma (BTC). However, its efficacy in the adjuvant setting remains controversial. Therefore, this study aimed to determine the prognostic significance of genomic biomarkers in resected BTC and their potential role in stratifying patients for adjuvant treatment. METHODS: We retrospectively...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adjuvants, Immunologic
Share to Bile Duct Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma

Share to Chemotherapy, Adjuvant

Share to Mutation

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 37341068
DOI: 10.1002/cam4.6261
PMCID: PMC10469713

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutational spectrum for guiding the decision of adjuvant treatment in patients with resected biliary tract carcinoma.PMID 37341068Read ↗

Comprehensive Genomic Profiles of Patients With Biliary Tract Cancer.Semantic proximity Read ↗

Effect of comprehensive cancer genomic profiling on therapeutic strategies and clinical outcomes in patients with advanced biliary tract cancer: A prospective multicenter studySemantic proximity Read ↗

Genomic feature and potential therapeutic target for cholangiocarcinomaSemantic proximity Read ↗

Targeted deep sequencing contributes to guiding personalized targeted therapy for advanced biliary tract cancer patients with non‑radical resection: A real‑world study.Semantic proximity Read ↗

Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targetsSemantic proximity Read ↗

Mutational spectrum and precision oncology for biliary tract carcinoma.Semantic proximity Read ↗

Comparative analysis of genomic profiles and clinical outcomes in cholangiocarcinoma and gallbladder cancer.Semantic proximity Read ↗

Clinical Implications of BRCA Mutations in Advanced Biliary Tract Cancer.Semantic proximity Read ↗

The potential role of comprehensive genomic profiling to guide targeted therapy for patients with biliary cancerSemantic proximity Read ↗

Translating cancer genomics for precision oncology in biliary tract cancers.Semantic proximity Read ↗

Genomic spectra of biliary tract cancer.Semantic proximity Read ↗

Genomic landscape of biliary tract cancer and corresponding targeted treatment strategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.